Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney disease.
Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney disease. Expert Rev Endocrinol Metab. 2017 09; 12(5):289-301.